Physician

Emori Bizer Carrara, M.D.

According to 2025 Medicare claims, Emori Carrara, M.D. (NPI: 1407983158) practices gastroenterology in the Louisville/Jefferson County, KY-IN market, with the plurality of this provider's patient population coming from Clark, IN. This provider's primary affiliated billing organization is GASTROENTEROLOGY HEALTH PARTNERS, PLLC (NPI: 1982963872; TIN: 454217766) and primary practice location at 47150-4053.

Carrara's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 675 traditional Medicare patients, billed 11,491 HCPCS/CPT codes, and received $224,860 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,464 prescription claims across 354 beneficiaries totaling $1,611,788 in drug costs, led by Gattex (Teduglutide). 2022 DME data shows 39 claims. Open Payments data shows 26 records totaling $495. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $132,077 and ending at $224,860. Concurrently, Part D prescription costs have risen steadily, from $155,600 to $1,611,788. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	630	2,840	$132,077
2016	764	6,377	$270,914
2017	677	10,143	$202,046
2018	781	18,261	$290,263
2019	807	10,792	$269,445
2020	685	9,808	$218,184
2021	684	11,188	$290,274
2022	722	13,109	$256,674
2023	691	12,633	$229,610
2024	675	11,491	$224,860

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	246	1,199	$155,600
2016	258	1,217	$250,655
2017	257	1,309	$449,752
2018	292	1,373	$383,493
2019	287	1,320	$666,248
2020	313	1,428	$1,290,521
2021	278	1,275	$1,412,618
2022	308	1,530	$957,894
2023	326	1,461	$1,639,052
2024	354	1,464	$1,611,788

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	22	$571
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	39	$5,853
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	171	172	$180
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	126	129	$92
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	128	132	$62
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	121	142	$60
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	128	201	$56

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gattex	Teduglutide	11	330	$990,756
Rinvoq	Upadacitinib	12	354	$108,826
Ocaliva	Obeticholic Acid	11	330	$105,485
Humira(Cf) Pen	Adalimumab	12	336	$77,033
Xifaxan	Rifaximin	26	678	$74,194

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$495	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Emori Bizer Carrara, M.D.?

Tedicare shows public-source Medicare data for Emori Bizer Carrara, M.D. (NPI 1407983158), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Emori Bizer Carrara, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Emori Bizer Carrara, M.D.?

Emori Bizer Carrara, M.D. is linked to GASTROENTEROLOGY HEALTH PARTNERS, PLLC (billing NPI 1982963872) in the available physician profile data.

Does Emori Bizer Carrara, M.D. have Open Payments data?

Emori Bizer Carrara, M.D. has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.